MDM2 and neoplasm: We observed that the MDM2 methylation was associated with gender (p = 0.021), AFP (p = 0.011), number of tumors (p = 0.002), tumor size (p = 0.001), vascular invasion (p = 0.040) and TNM stage (p = 0.037) (Table 3).